← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2018-03-12

Drug application

FDA Application #

ANDA204869

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PHARMOBEDIENT

First approval

2018-03-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown